These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24000936)

  • 21. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
    Kim J; Turan V; Oktay K
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
    Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
    Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
    George S; Feng Y; Manola J; Nucci MR; Butrynski JE; Morgan JA; Ramaiya N; Quek R; Penson RT; Wagner AJ; Harmon D; Demetri GD; Krasner C
    Cancer; 2014 Mar; 120(5):738-43. PubMed ID: 24222211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
    Wardley AM
    Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate.
    Quintero RB; Urban R; Lathi RB; Westphal LM; Dahan MH
    Fertil Steril; 2007 Oct; 88(4):879-85. PubMed ID: 17920403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction.
    Dahhan T; Balkenende E; van Wely M; Linn S; Goddijn M
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD010240. PubMed ID: 24213953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
    J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination.
    Wiser A; Shalom-Paz E; Reinblatt SL; Holzer H; Tulandi T
    Gynecol Endocrinol; 2012 Jul; 28(7):502-4. PubMed ID: 22122754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian stimulation for fertility preservation in patients with cancer.
    Quintero RB; Helmer A; Huang JQ; Westphal LM
    Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
    Torrisi R; Bagnardi V; Pruneri G; Ghisini R; Bottiglieri L; Magni E; Veronesi P; D'Alessandro C; Luini A; Dellapasqua S; Viale G; Goldhirsch A; Colleoni M
    Br J Cancer; 2007 Sep; 97(6):802-8. PubMed ID: 17712311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous leukocytoclastic vasculitis associated with letrozole.
    Digklia A; Tzika E; Voutsadakis IA
    J Oncol Pharm Pract; 2014 Apr; 20(2):146-8. PubMed ID: 23676512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
    Turan V; Bedoschi G; Moy F; Oktay K
    Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.